Leggett J D, Jessop D S, Fulford A J
Department of Anatomy, University of Bristol, Southwell Street, Bristol, UK.
Neuroscience. 2007 Jul 13;147(3):757-64. doi: 10.1016/j.neuroscience.2007.04.010. Epub 2007 Jun 15.
The involvement of nociceptin (N/OFQ) and the nociceptin/orphanin FQ peptide (NOP) receptor in behavior associated with stress and anxiety has been established but their role in the regulation of the hypothalamo-pituitary-adrenal (HPA) axis under conditions of stress has not been fully investigated. We used the selective NOP receptor antagonist UFP-101 to examine the contribution of endogenous N/OFQ to HPA axis control under conditions of restraint stress in the morning and the evening. We found that in the morning during the HPA axis circadian nadir rats exposed to restraint stress in both the presence and absence of UFP-101 exhibited significantly elevated plasma corticosterone at 30 min post-i.c.v. injection compared to the home cage control group. Additionally, rats treated with UFP-101 and exposed to restraint had significantly elevated corticosterone levels at 60 min post-i.c.v. injection compared to all other treatment groups. Interestingly, while there was a significant increase in the expression of CRF mRNA in the paraventricular nucleus (PVN) of rats exposed to restraint stress only, there was no comparable increase in those co-treated with UFP-101. There was no change in the expression of AVP or POMC mRNA in any of the treatment groups. In contrast, when carried out in the evening we observed significantly elevated plasma corticosterone in the vehicle-treated restraint group only at 30 min post-i.c.v. injection. There was no significant difference between the UFP-101-treated restraint group and either of the home cage control groups or the vehicle-treated restraint group. Additionally, in contrast to the morning study, UFP-101 did not prolong glucocorticoid release at the 60 min time-point. These results demonstrate for the first time a differential effect of UFP-101 on restraint stress-induced HPA axis activity characterized by significant prolongation of stress-induced activity in the morning but no significant effect on the response to restraint in the evening.
痛敏肽(N/OFQ)和痛敏肽/孤啡肽FQ肽(NOP)受体与应激和焦虑相关行为的关联已得到确认,但它们在应激条件下对下丘脑-垂体-肾上腺(HPA)轴调节中的作用尚未得到充分研究。我们使用选择性NOP受体拮抗剂UFP-101,来研究内源性N/OFQ在早晨和傍晚的束缚应激条件下对HPA轴调控的作用。我们发现,在早晨HPA轴昼夜最低点时,无论有无UFP-101,暴露于束缚应激的大鼠在脑室内注射后30分钟时血浆皮质酮水平均显著高于同笼对照组。此外,与所有其他治疗组相比,接受UFP-101治疗并暴露于束缚应激的大鼠在脑室内注射后60分钟时皮质酮水平显著升高。有趣的是,仅暴露于束缚应激的大鼠室旁核(PVN)中CRF mRNA表达显著增加,而联合UFP-101治疗的大鼠则无类似增加。任何治疗组中AVP或POMC mRNA的表达均无变化。相比之下,在傍晚进行实验时,我们观察到仅在脑室内注射后30分钟时,载体处理的束缚组血浆皮质酮显著升高。UFP-101处理的束缚组与同笼对照组或载体处理的束缚组之间无显著差异。此外,与早晨的研究不同,UFP-101在60分钟时间点并未延长糖皮质激素的释放。这些结果首次证明了UFP-101对束缚应激诱导的HPA轴活动具有不同的影响,其特征是在早晨显著延长应激诱导的活动,但对傍晚的束缚反应无显著影响。